Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sampson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Annals of Surgery|June 24, 2005
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxibArin K Greene, Ian P J Alwayn, Vania Nose, et al.
Journal of Medical Radiation Sciences|August 1, 2015
Evaluation of atlas-based auto-segmentation software in prostate cancer patientsStuart Greenham, Jenna Dean, Cheuk Kuen Kenneth Fu, et al.
Blood Advances|September 8, 2021
A novel activating JAK1 mutation in chronic eosinophilic leukemiaWilliam Shomali, Alisa Damnernsawad, Talent Theparee, et al.
Journal of the National Cancer Institute|March 2, 2006
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotypeGeorge N Naumov, Elise Bender, David Zurakowski, et al.
Medrxiv : the Preprint Server for Health Sciences|September 14, 2021
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patientsZoe L Lyski, Sunny Kim, David Xthona Lee, et al.
Case Reports in Hematology|February 7, 2022
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic LeukemiaZoe L Lyski, Myung Sun Kim, David Xthona Lee, et al.
Scientific Reports|March 9, 2019
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancerDaniel J Coleman, Lina Gao, Jacob Schwartzman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramDae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Annals of Surgery|June 24, 2005
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxibArin K Greene, Ian P J Alwayn, Vania Nose, et al.
Journal of Medical Radiation Sciences|August 1, 2015
Evaluation of atlas-based auto-segmentation software in prostate cancer patientsStuart Greenham, Jenna Dean, Cheuk Kuen Kenneth Fu, et al.
Blood Advances|September 8, 2021
A novel activating JAK1 mutation in chronic eosinophilic leukemiaWilliam Shomali, Alisa Damnernsawad, Talent Theparee, et al.
Journal of the National Cancer Institute|March 2, 2006
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotypeGeorge N Naumov, Elise Bender, David Zurakowski, et al.
Medrxiv : the Preprint Server for Health Sciences|September 14, 2021
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patientsZoe L Lyski, Sunny Kim, David Xthona Lee, et al.
Case Reports in Hematology|February 7, 2022
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic LeukemiaZoe L Lyski, Myung Sun Kim, David Xthona Lee, et al.
Scientific Reports|March 9, 2019
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancerDaniel J Coleman, Lina Gao, Jacob Schwartzman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2021
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity ProgramDae-Hwan Kim, Duanchen Sun, William K Storck, et al.
Pageof 2